
Opinion|Videos|March 20, 2025
Managing ADC Toxicities and Infusion Reactions With Supportive Care Strategies
Panelists discuss how antibody-drug conjugates (ADCs) often cause toxic adverse events (AEs). Supportive care includes antiemetics, corticosteroids, and growth factors. Infusion reactions are managed with premedication and slow titration.
Advertisement
Episodes in this series

Video content above has been prompted by the following:
- Current ADCs in this space have fairly toxic AE profiles. What supportive care agents do you utilize when treating a patient with ADC therapy?
- In your practice, how do you address the potential for infusion-related reactions, and how do you manage their occurrence?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Priority Review to Finerenone for Chronic Kidney Disease in Adults With Type 1 Diabetes
2
Expanding the Field: Who Now Qualifies for CGM, AID, and Continuous Ketone Monitoring?
3
Depression Common in Asthma, But Moderate to Severe Disease Worsens Outcomes
4
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer?
5







































































































































